From interview with Takeda head of R&D:
Takeda has spun out 10 companies rather than just dump efforts. And Plump has been promising that same kind of delicate approach as he looks at some R&D areas — like ophthalmology — and locations that fall outside their sweet spot.
If anyone thinks the OBU isn’t on the chopping block you aren’t listening.
Takeda has spun out 10 companies rather than just dump efforts. And Plump has been promising that same kind of delicate approach as he looks at some R&D areas — like ophthalmology — and locations that fall outside their sweet spot.
If anyone thinks the OBU isn’t on the chopping block you aren’t listening.